Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Menopause. 2022 Jul 1;29(7):805–815. doi: 10.1097/GME.0000000000001988

Table 3.

Adjusted Associations between Pre-FMP Psychosocial and Health-Related Predictors and High Depressive Symptoms during the Post-FMP (Postmenopause) (N=924, Number of observations=6,240)

Model* CES-D≥16 during postmenopause
OR (95% CI)
p-value
Pre-FMP CES-D trajectory group
 Consistently low CES-D scores (REF) --- ---
 Mid-level CES-D scores 3.59 (2.64–4.88) <.0001
 High CES-D scores 14.73 (9.26–23.42) <.0001
Time (years) 0.94 (0.92–0.96) <.0001
Age at baseline (years) 0.95 (0.90–1.00) 0.05
Race/Ethnicity
 White (REF) --- ---
 Black 1.37 (0.95–1.98) 0.09
 Chinese 1.21 (0.62–2.39) 0.58
 Hispanic 0.76 (0.24–2.37) 0.63
 Japanese 1.69 (0.81–3.51) 0.16
Education at baseline
 Less than high school 1.45 (0.80–2.63) 0.22
 High school/some college 0.86 (0.64–1.16) 0.34
 College/more than college (REF) --- ---
Anxiety symptom score ≥ 4 at ≥ 50% of visits prior to FMP 1.46 (1.02–2.10) 0.04
Social support (AUC) prior to FMP 0.94 (0.90–0.98) 0.004
Sleep problems reported at ≥ 50% of visits prior to FMP 1.35 (1.01–1.81) 0.04
Poor role physical score at ≥ 50% of visits prior to FMP 1.78 (1.30–2.44) 0.0003
VMS at ≥ 50% of visits prior to FMP 1.67 (1.26–2.23) 0.0004
History of any childhood maltreatment 1.40 (1.07–1.83) 0.01

FMP, Final Menstrual Period, CES-D, Center for Epidemiologic Studies-Depression scale; OR, Odds Ratio; CI, Confidence Interval; REF, referent group; AUC, Area Under the Curve; VMS, Vasomotor symptoms.

a

Adjusted for site. Significant p-values in bold font.